First United Bank & Trust reduced its position in shares of CME Group Inc. (NASDAQ:CME – Get Rating) by 1.5% during the 2nd quarter, HoldingsChannel reports. The firm owned 4,061 shares of the financial services provider's stock after selling 63 shares during the period. First United Bank & Trust's holdings in CME Group were worth $831,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of the company. MUFG Americas Holdings Corp increased its holdings in shares of CME Group by 3.8% in the 1st quarter. MUFG Americas Holdings Corp now owns 16,886 shares of the financial services provider's stock valued at $4,017,000 after acquiring an additional 611 shares during the period. Assenagon Asset Management S.A. increased its holdings in shares of CME Group by 2,556.7% in the 1st quarter. Assenagon Asset Management S.A. now owns 133,100 shares of the financial services provider's stock valued at $31,659,000 after acquiring an additional 128,090 shares during the period. Capital International Sarl increased its holdings in shares of CME Group by 14.9% in the 1st quarter. Capital International Sarl now owns 126,176 shares of the financial services provider's stock valued at $30,012,000 after acquiring an additional 16,316 shares during the period. GHP Investment Advisors Inc. increased its holdings in shares of CME Group by 4.9% in the 1st quarter. GHP Investment Advisors Inc. now owns 10,035 shares of the financial services provider's stock valued at $2,387,000 after acquiring an additional 472 shares during the period. Finally, Cambridge Investment Research Advisors Inc. increased its holdings in shares of CME Group by 5.3% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 37,169 shares of the financial services provider's stock valued at $7,608,000 after acquiring an additional 1,879 shares during the period. 85.56% of the stock is currently owned by hedge funds and other institutional investors.
Get CME Group alerts:Insider Activity
In related news, Director Daniel R. Glickman sold 500 shares of the company's stock in a transaction dated Wednesday, August 31st. The stock was sold at an average price of $196.39, for a total value of $98,195.00. Following the completion of the transaction, the director now owns 14,597 shares of the company's stock, valued at approximately $2,866,704.83. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Daniel R. Glickman sold 500 shares of the company's stock in a transaction dated Wednesday, August 31st. The stock was sold at an average price of $196.39, for a total value of $98,195.00. Following the completion of the transaction, the director now owns 14,597 shares of the company's stock, valued at approximately $2,866,704.83. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Derek Sammann sold 4,000 shares of the company's stock in a transaction dated Friday, September 9th. The stock was sold at an average price of $201.51, for a total value of $806,040.00. Following the completion of the transaction, the insider now directly owns 13,333 shares of the company's stock, valued at approximately $2,686,732.83. The disclosure for this sale can be found here. Insiders sold a total of 10,511 shares of company stock valued at $2,123,186 in the last quarter. 0.30% of the stock is currently owned by company insiders.
CME Group Stock Performance
Shares of CME stock traded down $2.25 on Friday, hitting $181.08. The company had a trading volume of 1,265,750 shares, compared to its average volume of 1,331,518. The firm has a market cap of $65.09 billion, a P/E ratio of 22.47, a price-to-earnings-growth ratio of 2.92 and a beta of 0.40. The company has a 50-day moving average price of $198.09 and a 200-day moving average price of $210.08. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a twelve month low of $178.75 and a twelve month high of $256.94.CME Group (NASDAQ:CME – Get Rating) last issued its quarterly earnings data on Wednesday, July 27th. The financial services provider reported $1.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.05. The business had revenue of $1.24 billion during the quarter, compared to analysts' expectations of $1.25 billion. CME Group had a return on equity of 9.65% and a net margin of 60.43%. The company's revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.64 EPS. As a group, equities research analysts predict that CME Group Inc. will post 7.96 earnings per share for the current fiscal year.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 27th. Stockholders of record on Friday, September 9th will be issued a $1.00 dividend. The ex-dividend date of this dividend is Thursday, September 8th. This represents a $4.00 annualized dividend and a dividend yield of 2.21%. CME Group's dividend payout ratio (DPR) is presently 49.63%.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on the company. Morgan Stanley cut their price target on CME Group from $242.00 to $226.00 and set an "equal weight" rating on the stock in a report on Thursday, July 28th. Credit Suisse Group cut their price target on CME Group from $216.00 to $210.00 and set a "neutral" rating on the stock in a report on Tuesday, September 6th. Jefferies Financial Group started coverage on CME Group in a research note on Tuesday, May 31st. They set a "buy" rating and a $267.00 target price on the stock. UBS Group dropped their target price on CME Group from $246.00 to $240.00 and set a "buy" rating on the stock in a research note on Tuesday, August 2nd. Finally, Raymond James downgraded CME Group from an "outperform" rating to a "market perform" rating in a research note on Monday, August 15th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $230.80.
CME Group Company Profile
(Get Rating)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
Read More
- Get a free copy of the StockNews.com research report on CME Group (CME)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 2 Semiconductor Stocks To Watch For Reversals
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Get Rating).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.